Daily BriefsJapan

Daily Brief Japan: Integral Corporation, Sekisui Chemical, Tokyo Stock Exchange Tokyo Price Index Topix and more

In today’s briefing:

  • Integral Corporation IPO: The Bear Case
  • Sekisui Chem (4204) | Potential of Perovskite PV
  • Even if Proper Nomination Process Is Skipped, It May Be Considered Better than Zero Women Directors


Integral Corporation IPO: The Bear Case

By Arun George

  • Integral Corporation (5842 JP) is an independent Japanese private equity firm seeking to raise about US$175 million. The pricing is on 4 September, and the listing is on 20 September. 
  • In Integral Corporation IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The bear case rest on the declining mix of fee-earning AUM, growth driven by volatile investment income and uninspiring 1HFY22 performance in fee-related revenue growth and margin.

Sekisui Chem (4204) | Potential of Perovskite PV

By Mark Chadwick

  • Perovskite solar cells have the potential to be more efficient and less expensive than traditional silicon solar cells.
  • Recent research suggests that the global market for Perovskite PV could be worth around $12 billion in 2032
  • If Sekisui Chemical were to take a 10% market share, then the potential impact on earnings could be 22%.

Even if Proper Nomination Process Is Skipped, It May Be Considered Better than Zero Women Directors

By Aki Matsumoto

  • There are concerns about the ability of female directors hired solely for the purpose of recruiting women directors without a reasonable director nomination process to demonstrate strength on the BOD.
  • Board diversity issues were considered a low priority until more institutional investors voted against the top management of companies with zero female directors at shareholder meetings.
  • Given the small population of full-time female employees and the relatively young age bias, it’s likely that even in 2030, most female board members will be relying on outside talent.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars